GlassScriptPhysician profile
Mehak Nangrani
NPI 1649567660
$4,617.98
in general payments reported to CMS, 2019-2025
38 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $409 · 2021: $1,300 · 2022: $766 · 2023: $857 · 2024: $530 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $508.75 | 2021-2025 | |
| Amgen INC. | $442.30 | 2019-2025 | Repatha, Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $386.25 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $339.28 | 2022-2025 | |
| Lilly USA, LLC | $319.29 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $281.80 | 2021-2025 | Rybelsus, Ozempic |
| Optinose US, INC. | $230.07 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $171.93 | 2021-2024 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $171.60 | 2019-2023 | Trelegy Ellipta |
| Medicure Pharma INC. | $170.77 | 2020-2021 | |
| Shield Therapeutics INC | $137.00 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $124.14 | 2019-2023 | |
| Esperion Therapeutics, INC. | $122.85 | 2021-2024 | Nexletol |
| Amneal Pharmaceuticals LLC | $100.86 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $89.12 | 2019-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $82.33 | 2020-2022 | |
| Pfizer INC. | $77.71 | 2024-2025 | |
| Kvk-Tech, INC. | $70.17 | 2019 | |
| Abbott Laboratories | $69.19 | 2022-2023 | Gallant, Jot Dx |
| Janssen Pharmaceuticals, INC | $67.89 | 2023-2024 | Spravato, Xarelto |
| Allergan, INC. | $65.96 | 2020 | |
| Medtronic, INC. | $65.53 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.19 | 2022-2024 | Trulance, Xifaxan |
| Exact Sciences Corporation | $51.60 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceuticals, INC. | $51.02 | 2021 | |
| Amarin Pharma, INC. | $45.65 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $43.14 | 2021-2025 | Seglentis, Livalo, Zoryve |
| Biohaven Pharmaceutical Holding Company LTD. | $40.01 | 2022 | |
| Medtronic Minimed, INC. | $37.64 | 2020 | |
| Eisai INC. | $32.09 | 2021 | |
| Dexcom, INC. | $29.52 | 2022-2025 | Dexcom G6 Transmitter |
| Currax Pharmaceuticals LLC | $27.21 | 2020 | |
| Valeritas, INC. | $25.24 | 2019 | |
| Astellas Pharma US INC | $21.74 | 2024 | Veozah |
| Gilead Sciences, INC. | $18.24 | 2019 | |
| Boston Scientific Corporation | $16.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.84 | 2022 | |
| Philips North America LLC | $13.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehak Nangrani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.